Teleabortion Prevention Act of 2023

12/15/2023, 3:53 PM

Teleabortion Prevention Act of 2023

This bill restricts the use of telehealth for chemical abortions (also known as medication abortions).

Specifically, it requires a provider who dispenses or prescribes medication for a chemical abortion to physically examine the patient, be physically present at the location of the chemical abortion, and schedule a follow-up visit for the patient. The bill provides an exception for a chemical abortion that is necessary to save the life of a mother whose life is endangered by a physical disorder, illness, injury, or condition.

The bill establishes criminal penalties—a fine, a prison term of up to two years, or both—for a provider who does not comply with the requirements.

A patient who undergoes a chemical abortion may not be prosecuted.

Bill 118 HR 421, also known as the Teleabortion Prevention Act of 2023, is a piece of legislation introduced in the US Congress with the aim of preventing the practice of teleabortion. Teleabortion is the provision of abortion services through telemedicine, allowing women to access abortion pills without having to visit a healthcare provider in person.

The bill seeks to prohibit the use of telemedicine for the purpose of providing abortion services, stating that healthcare providers must physically examine a patient before prescribing abortion-inducing medication. It also requires that the prescribing healthcare provider be licensed in the state where the patient is located.

Supporters of the bill argue that teleabortion poses risks to women's health and safety, as it may not allow for proper medical evaluation and follow-up care. They believe that in-person consultations are necessary to ensure that women are making informed decisions about their reproductive health. Opponents of the bill, on the other hand, argue that teleabortion is a safe and effective way for women to access abortion care, especially in areas where there are limited healthcare providers. They believe that restricting teleabortion could limit women's access to safe and legal abortion services. Overall, the Teleabortion Prevention Act of 2023 is a controversial piece of legislation that raises important questions about women's access to reproductive healthcare and the role of telemedicine in providing such services. It is currently being debated in Congress, with both supporters and opponents voicing their opinions on the matter.
Congress
118

Number
HR - 421

Introduced on
2023-01-20

# Amendments
0

Sponsors
+5

Cosponsors
+5

Variations and Revisions

1/20/2023

Status of Legislation

Bill Introduced
Introduced to House
House to Vote
Introduced to Senate
Senate to Vote

Purpose and Summary

Teleabortion Prevention Act of 2023

This bill restricts the use of telehealth for chemical abortions (also known as medication abortions).

Specifically, it requires a provider who dispenses or prescribes medication for a chemical abortion to physically examine the patient, be physically present at the location of the chemical abortion, and schedule a follow-up visit for the patient. The bill provides an exception for a chemical abortion that is necessary to save the life of a mother whose life is endangered by a physical disorder, illness, injury, or condition.

The bill establishes criminal penalties—a fine, a prison term of up to two years, or both—for a provider who does not comply with the requirements.

A patient who undergoes a chemical abortion may not be prosecuted.

Bill 118 HR 421, also known as the Teleabortion Prevention Act of 2023, is a piece of legislation introduced in the US Congress with the aim of preventing the practice of teleabortion. Teleabortion is the provision of abortion services through telemedicine, allowing women to access abortion pills without having to visit a healthcare provider in person.

The bill seeks to prohibit the use of telemedicine for the purpose of providing abortion services, stating that healthcare providers must physically examine a patient before prescribing abortion-inducing medication. It also requires that the prescribing healthcare provider be licensed in the state where the patient is located.

Supporters of the bill argue that teleabortion poses risks to women's health and safety, as it may not allow for proper medical evaluation and follow-up care. They believe that in-person consultations are necessary to ensure that women are making informed decisions about their reproductive health. Opponents of the bill, on the other hand, argue that teleabortion is a safe and effective way for women to access abortion care, especially in areas where there are limited healthcare providers. They believe that restricting teleabortion could limit women's access to safe and legal abortion services. Overall, the Teleabortion Prevention Act of 2023 is a controversial piece of legislation that raises important questions about women's access to reproductive healthcare and the role of telemedicine in providing such services. It is currently being debated in Congress, with both supporters and opponents voicing their opinions on the matter.
Alternative Names
Official Title as IntroducedTo prohibit chemical abortions performed without the presence of a healthcare provider, and for other purposes.

Policy Areas
Crime and Law Enforcement

Potential Impact
Abortion•
Civil actions and liability•
Health personnel•
Health technology, devices, supplies•
Medical ethics•
Medical tests and diagnostic methods

Comments

Recent Activity

Latest Summary6/2/2023

Teleabortion Prevention Act of 2023

This bill restricts the use of telehealth for chemical abortions (also known as medication abortions).

Specifically, it requires a provider who dispenses or prescribes medication for a che...


Latest Action1/20/2023
Referred to the House Committee on the Judiciary.